Syndax Pharmaceuticals (FRA:1T3) OCF Margin %: -77.62% (As of Mar. 2026)

What is Syndax Pharmaceuticals OCF Margin %?

Syndax Pharmaceuticals FRA:1T3 -0.94% 25 OCF Margin % is -77.62% as of Mar. 2026. GuruFocus rates FRA:1T3 with a GF Score™ of 25/100. The stock has 7 warning signs investors should review. Among 958 Biotechnology companies, Syndax Pharmaceuticals ranks worse than 56.99% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Syndax Pharmaceuticals's Cash Flow from Operations for the three months ended in Mar. 2026 was €-43.5 Mil. Syndax Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was €56.1 Mil. Therefore, Syndax Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was -77.62%.

As of today, Syndax Pharmaceuticals's current OCF Yield % is -14.73%.

The historical rank and industry rank for Syndax Pharmaceuticals's OCF Margin % or its related term are showing as below:

FRA:1T3' s OCF Margin % Range Over the Past 10 Years
Min: -4697.43 Med: -2564.46 Max: 20.85
Current: -128.01

During the past 13 years, the highest OCF Margin % of Syndax Pharmaceuticals was 20.85%. The lowest was -4697.43%. And the median was -2564.46%.

FRA:1T3's OCF Margin % is ranked worse than
56.99% of 958 companies
in the Biotechnology industry
Industry Median: -68.59 vs FRA:1T3: -128.01

Syndax Pharmaceuticals OCF Margin % Related Terms

Syndax Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Syndax Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syndax Pharmaceuticals OCF Margin % Chart

Syndax Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

20.85

0.00

-1,160.93

-187.40

Syndax Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															-474.81	-231.29	-153.77	-101.11	-77.62

FRA:1T3 vs CAPR, SLS, AGIO: OCF Margin % Comparison

For the Biotechnology subindustry, Syndax Pharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syndax Pharmaceuticals OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syndax Pharmaceuticals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Syndax Pharmaceuticals's OCF Margin % falls into.

Save Embed

25GF Score

Syndax Pharmaceuticals Inc FRA:1T3

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Syndax Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Syndax Pharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-275.825	/	147.189
	=	-187.40 %

Syndax Pharmaceuticals's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-43.548	/	56.107
	=	-77.62 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -77.62% mean?

Syndax Pharmaceuticals (FRA:1T3) has a OCF Margin % of -77.62% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Syndax Pharmaceuticals and its competitors. According to the industry distribution chart, Syndax Pharmaceuticals ranks #546 out of 958 companies in the Biotechnology industry, placing it in the top 57%.

Is Syndax Pharmaceuticals' OCF Margin % too high?

Syndax Pharmaceuticals' current OCF Margin % is -77.62%. Based on the distribution chart, Syndax Pharmaceuticals ranks #546 out of 958 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Syndax Pharmaceuticals has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.

How does Syndax Pharmaceuticals' OCF Margin % compare to CAPR and SLS?

According to the Biotechnology industry distribution chart, Syndax Pharmaceuticals ranks #546 out of 958 companies for OCF Margin %. This places Syndax Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Syndax Pharmaceuticals and its competitors. Syndax Pharmaceuticals's current OCF Margin % is -77.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Syndax Pharmaceuticals stock overvalued right now?

Syndax Pharmaceuticals (FRA:1T3) has a current OCF Margin % of -77.62%. The current OCF Margin % is -77.62%. Syndax Pharmaceuticals' overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Syndax Pharmaceuticals (FRA:1T3), the current OCF Margin % is -77.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syndax Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies CAPR SLS AGIO VCEL PVLA TSHA GENB QURE ATAI NVAX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges SNDX:USA 1T3:Germany

Address 730 Third Avenue, 9th Floor, New York, NY, USA, 10017

Website https://www.syndax.com

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

25GF Score

Get the complete analysis for FRA:1T3

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.43

Price

View FRA:1T3 Analysis

See OCF Margin % data for all stocks →